Pharos Energy reported 2025 production in line with guidance, net cash of $40.2 million and a recommended final dividend of 0.9317 pence per share, taking the full-year payout to 1.331..
EDX Medical will serve as the primary delivery partner for the Scottish Prostate Cancer Initiative, which plans to offer free PSA testing to 25,000 men across Scotland and explore ways..
Elemental reported significant year-over-year growth in 2025, driven by asset contributions and its EMX merger, alongside record quarterly results. The company expects further gains in 2026 with projected revenue of..
Phase 1 infill drilling at the Molefe copper mine confirmed near-surface oxide mineralisation and grades consistent with the expansion mine plan, while identifying a new mineralised zone extending about 250..
The company reported unaudited half-year results for the six months to 31 December 2025, with NAV per share total return of 69.3% and share price total return of 83.1%, alongside..
TEAM has completed its acquisition of WH Ireland after the Court Order was filed with the Registrar of Companies. WH Ireland is now a wholly owned subsidiary of Team, with..
The latest fact sheet for CQS Natural Resources Growth and Income PLC, dated 28 February 2026, is now available, outlining recent performance, portfolio activity and key holdings...
Improved kiln efficiency, new capacity coming online in 2026, and increasing sales across mining, agriculture and industrial sectors underline Limeco’s ongoing ramp-up phase...
Criterium Energy reported record 2025 reserves, including 7.7 MMboe of 2P reserves, a US$50 million 2P NPV10, and higher contingent resources driven by gas reserve additions and oil development opportunities..
Brava Health is building a time-centred health and wellness proposition that focuses on better living, clearer outcomes and stronger long-term relevance...
Tirupati Graphite said it has published a prospectus covering new shares linked to its December 2025 placing and the conversion of £6.4 million of loan notes into equity, with trading..
CMC Markets has appointed Emma Earp as a Non-Executive Director, effective 1 April 2026. She will also join the Audit, Nomination, Remuneration and Risk Committees, bringing more than 15 years..
Chinese equities gained ground as lower oil prices improved sentiment, with investors rotating into strategic and technology-linked sectors as market conditions turned more supportive...
Genflow Biosciences (LON:GENF) has secured fresh funding and grant support to accelerate its gene therapy research, highlighting growing momentum in the longevity biotech space. With a blend of equity financing..
Full-year results highlight double-digit growth across key metrics, strengthened capital position, and continued M&A momentum, with a 6% dividend increase proposed...
Nuformix strengthens its NXP002 programme with US orphan drug designation, unlocking market exclusivity in a region accounting for the majority of IPF revenues. With fresh capital and ongoing partner discussions,..
Pharos Energy reported 2025 production in line with guidance, net cash of $40.2 million and a recommended final dividend of 0.9317 pence per share, taking the full-year payout to 1.331 pence per share. The company said drilling is progressing in Vietnam and Egypt, with updated 2026 production guidance of 5,200 to 6,400 boepd net...
EDX Medical will serve as the primary delivery partner for the Scottish Prostate Cancer Initiative, which plans to offer free PSA testing to 25,000 men across Scotland and explore ways to improve early detection and diagnosis of the disease...
Elemental reported significant year-over-year growth in 2025, driven by asset contributions and its EMX merger, alongside record quarterly results. The company expects further gains in 2026 with projected revenue of up to $94.5 million and increased GEO production...
Phase 1 infill drilling at the Molefe copper mine confirmed near-surface oxide mineralisation and grades consistent with the expansion mine plan, while identifying a new mineralised zone extending about 250 metres to the east. Jubilee said Phase 2 drilling is under way to define the extension and support a future formal resource estimate...
The company reported unaudited half-year results for the six months to 31 December 2025, with NAV per share total return of 69.3% and share price total return of 83.1%, alongside updates on its dividend policy, share issuance and portfolio management transition...
TEAM has completed its acquisition of WH Ireland after the Court Order was filed with the Registrar of Companies. WH Ireland is now a wholly owned subsidiary of Team, with AIM cancellation expected on 25 March 2026 and shareholder settlement due by 7 April 2026...
The latest fact sheet for CQS Natural Resources Growth and Income PLC, dated 28 February 2026, is now available, outlining recent performance, portfolio activity and key holdings...
Improved kiln efficiency, new capacity coming online in 2026, and increasing sales across mining, agriculture and industrial sectors underline Limeco’s ongoing ramp-up phase...
Criterium Energy reported record 2025 reserves, including 7.7 MMboe of 2P reserves, a US$50 million 2P NPV10, and higher contingent resources driven by gas reserve additions and oil development opportunities in Indonesia...
Brava Health is building a time-centred health and wellness proposition that focuses on better living, clearer outcomes and stronger long-term relevance...
Tirupati Graphite said it has published a prospectus covering new shares linked to its December 2025 placing and the conversion of £6.4 million of loan notes into equity, with trading on the London Stock Exchange expected to resume on 24 March 2026 and admission of the new shares due on 27 March 2026...
CMC Markets has appointed Emma Earp as a Non-Executive Director, effective 1 April 2026. She will also join the Audit, Nomination, Remuneration and Risk Committees, bringing more than 15 years of banking and finance legal experience...
Chinese equities gained ground as lower oil prices improved sentiment, with investors rotating into strategic and technology-linked sectors as market conditions turned more supportive...
Genflow Biosciences (LON:GENF) has secured fresh funding and grant support to accelerate its gene therapy research, highlighting growing momentum in the longevity biotech space. With a blend of equity financing and non-dilutive backing, the company is advancing its mission to tackle age-related diseases at the genetic level...
Full-year results highlight double-digit growth across key metrics, strengthened capital position, and continued M&A momentum, with a 6% dividend increase proposed...
Nuformix strengthens its NXP002 programme with US orphan drug designation, unlocking market exclusivity in a region accounting for the majority of IPF revenues. With fresh capital and ongoing partner discussions, the company is positioning itself to advance a differentiated inhaled therapy while negotiating from strength...
